TNBC: Weekly nab-paclitaxel delivers, denosumab disappoints
SAN ANTONIO – Among patients with TNBC who were treated with weekly nab-paclitaxel, 60.4% achieved pCR, compared with 50.0% who were treated with nab-paclitaxel on days 1 and 8 every 3 weeks.